High-dose dobutamine-atropine stress cardiovascular MR imaging after coronary revascularization in patients with wall motion abnormalities at rest

Radiology

Volumn 233, Issue 1, 2004, Pages 210-216

  Wahl, Andreas ^a,b   Paetsch, Ingo ^a   Roethemeyer, Stefan ^a,c   Klein, Christoph ^a   Fleck, Eckart ^a   Nagel, Eike ^a  

^a DEUTSCHES HERZZENTRUM BERLIN   (Germany)

^b BERN UNIVERSITY HOSPITAL   (Switzerland)

^c Heart Center   (Germany)

Author keywords

Coronary angiography, comparative studies; Coronary vessels, MR; Coronary vessels, stenosis or obstruction; Heart, ischemia; Magnetic resonance (MR), cine study

Indexed keywords

ATROPINE; DOBUTAMINE;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CARDIOVASCULAR RISK; CORONARY ARTERY BYPASS GRAFT; DEVICE; DIABETES MELLITUS; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DRUG MEGADOSE; EXERCISE TEST; FEMALE; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HEART MUSCLE REVASCULARIZATION; HEART RATE; HEART VENTRICLE EXTRASYSTOLE; HEART VENTRICLE WALL MOTION; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; HYPOTENSION; IMAGE ANALYSIS; MAJOR CLINICAL STUDY; MALE; NAUSEA; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SMOKING; THORAX PAIN;

ADULT; AGED; AGED, 80 AND OVER; ATROPINE; CARDIOTONIC AGENTS; CORONARY ANGIOGRAPHY; CORONARY DISEASE; CORONARY STENOSIS; DOBUTAMINE; EXERCISE TEST; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MUSCARINIC ANTAGONISTS; MYOCARDIAL ISCHEMIA; MYOCARDIAL REVASCULARIZATION; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; SINGLE-BLIND METHOD; VENTRICULAR DYSFUNCTION;

EID: 4644262494     PISSN: 00338419     EISSN: None     Source Type: Journal    
DOI: 10.1148/radiol.2331030463     Document Type: Article

References (36)

1. Murray CJ, Lopez AD. Mortality by cause for eight regions of the world: global burden of disease study. Lancet 1997; 349:1269-1276.
2. Geleijnse ML, Fioretti PM, Roelandt JR. Methodology, feasibility, safety and diagnostic accuracy of dobutamine stress echocardiography. J Am Coll Cardiol 1997; 30:595-606.
3. Upton MT, Rerych SK, Newman GE, Port S, Cobb FR, Jones RH. Detecting abnormalities in left ventricular function during exercise before angina and ST-segment depression. Circulation 1980; 62:341-349.
4. Marcovitz PA, Armstrong WF. Accuracy of dobutamine stress echocardiography in detecting coronary artery disease. Am J Cardiol 1992; 69:1269-1273.
5. Hoffmann R, Lethen H, Marwick T, et al. Analysis of interinstitutional observer agreement in interpretation of dobutamine stress echocardiograms. J Am Coll Cardiol 1996; 27:330-336.
6. Zoghbi WA, Barasch E. Dobutamine MRI: a serious contender in pharmacological stress imaging? Circulation 1999; 99:730-732.
7. Nagel E, Lehmkuhl HB, Bocksch W, et al. Noninvasive diagnosis of ischemia-induced wall motion abnormalities with the use of high-dose dobutamine stress MRI: comparison with dobutamine stress echocardiography. Circulation 1999; 99:763-770.
8. Hundley WG, Hamilton CA, Thomas MS, et al. Utility of fast cine magnetic resonance imaging and display for the detection of myocardial ischemia in patients not well suited for second harmonic stress echocardiography. Circulation 1999; 100:1697-1702.
9. Baer FM, Voth E, Theissen P, Schicha H, Sechtem U. Gradient-echo magnetic resonance imaging during incremental dobutamine infusion for the localization of coronary artery stenoses. Eur Heart J 1994; 15:218-225.
10. van Rugge FP, van der Wall EE, Spanjersberg SJ, et al. Magnetic resonance Imaging during dobutamine stress for detection and localization of coronary artery disease: quantitative wall motion analysis using a modification of the centerline method. Circulation 1994; 90:127-138.
11. Nagel E, Lorenz C, Baer F, et al. Stress cardiovascular magnetic resonance: consensus panel report. J Cardiovasc Magn Reson 2001; 3:267-281.
12. Schiller NB, Shah PM, Crawford M, et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr 1989; 2:358-367.
13. Gould KL, Lipscomb K, Hamilton GW. Physiologic basis for assessing critical coronary stenosis: instantaneous flow response and regional distribution during coronary hyperemia as measures of coronary flow reserve. Am J Cardiol 1974; 33:87-94.
14. Poldermans D, Fioretti PM, Boersma E, et al. Safety of dobutamine-atropine stress echocardiography in patients with suspected or proven coronary artery disease. Am J Cardiol 1994; 73:456-459.
15. Picano E, Mathias W, Pingitore A, Bigi R, Previtali M. Safety and tolerability of dobutamine-atropine stress echocardiography: a prospective, multicentre study. Echo Dobutamine International Cooperative Study Group. Lancet 1994; 344:1190-1192.
16. Secknus MA, Marwick TH. Evolution of dobutamine echocardiography protocols and indications: safety and side effects in 3,011 studies over 5 years. J Am Coll Cardiol 1997; 29:1234-1240.
17. Mathias W, Arruda A, Santos FC, et al. Safety of dobutamine-atropine stress echocardiography: a prospective experience of 4,033 consecutive studies. J Am Soc Echocardiogr 1999; 12:785-791.
18. Takeuchi M, Miura Y, Sonoda S, Kuroiwa A. Comparison of three different protocols for dobutamine stress echocardiography: does the addition of atropine increase complications, and does it improve diagnostic accuracy? Echocardiography 1999; 16:347-355.
19. Lattanzi F, Picano E, Adamo E, Varga A. Dobutamine stress echocardiography: safety in diagnosing coronary artery disease. Drug Saf 2000; 22:251-262.
20. Gibbons RJ, Balady GJ, Bricker JT, et al. ACC/AHA 2002 guideline update for exercise testing: summary article - a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (committee to update the 1997 exercise testing guidelines). Circulation 2002; 106:1883-1892.
21. Pina IL, Balady GJ, Hanson P, Labovitz AJ, Madonna DW, Myers J. Guidelines for clinical exercise testing laboratories: a statement for healthcare professionals from the Committee on Exercise and Cardiac Rehabilitation, American Heart Association. Circulation 1995; 91:912-921.
22. Rodgers GP, Ayanian JZ, Balady G, et al. American College of Cardiology/American Heart Association clinical competence statement on stress testing: a report of the American College of Cardiology/American Heart Association/American College of Physicians-American Society of Internal Medicine Task Force on Clinical Competence. Circulation 2000; 102:1726-1738.
23. Kanal E, Borgstede JP, Barkovich AJ, et al. American College of Radiology white paper on MR safety. AJR Am J Roentgenol 2002; 178:1335-1347.
24. Botas J, Stadius ML, Bourassa MG, et al. Angiographic correlates of lesion relevance and suitability for percutaneous transluminal coronary angioplasty and coronary artery bypass grafting in the Bypass Angioplasty Revascularization Investigation study (BARI). Am J Cardiol 1996; 77:805-814.
25. Saucedo JF, Popma JJ, Kennard ED, et al. Relation of coronary artery size to 1-year clinical events after new device angioplasty of native coronary arteries (a New Approach to Coronary Intervention [NACI] registry report). Am J Cardiol 2000; 85:166-171.
26. Marwick T, D'Hondt AM, Baudhuin T, et al. Optimal use of dobutamine stress for the detection and evaluation of coronary artery disease: combination with echocardiography or scintigraphy, or both? J Am Coll Cardiol 1993; 22:159-167.
27. Nesto RW, Kowalchuk GJ. The ischemic cascade: temporal sequence of hemodynamic, electrocardiographic and symptomatic expressions of ischemia. Am J Cardiol 1987; 59:23C-30C.
28. Pennell DJ, Underwood SR, Manzara CC, et al. Magnetic resonance imaging during dobutamine stress in coronary artery disease. Am J Cardiol 1992; 70:34-40.
29. van Rugge FP, van der Wall EE, de Roos A, Bruschke AV. Dobutamine stress magnetic resonance imaging for detection of coronary artery disease. J Am Coll Cardiol 1993; 22:431-439.
30. Ling LH, Pellikka PA, Mahoney DW, et al. Atropine augmentation in dobutamine stress echocardiography: role and incremental value in a clinical practice setting. J Am Coll Cardiol 1996; 28:551-557.
31. White CW, Wright CB, Doty DB, et al. Does visual interpretation of the coronary arteriogram predict the physiologic importance of a coronary stenosis? N Engl J Med 1984; 310:819-824.
32. Harrison DG, White CW, Hiratzka LF, et al. The value of lesion cross-sectional area determined by quantitative coronary angiography in assessing the physiologic significance of proximal left anterior descending coronary arterial stenoses. Circulation 1984; 69:1111-1119.
33. Glagov S, Weisenberg E, Zarins CK, Stankunavicius R, Kolettis GJ. Compensatory enlargement of human atherosclerotic coronary arteries. N Engl J Med 1987; 316:1371-1375.
34. Power TP, Kramer CM, Shaffer AL, et al. Breath-hold dobutamine magnetic resonance myocardial tagging: normal left ventricular response. Am J Cardiol 1997; 80:1203-1207.
35. Thiele H, Nagel E, Paetsch I, et al. Functional cardiac MR imaging with steady-state free precession (SSFP) significantly improves endocardial border delineation without contrast agents. J Magn Reson Imaging 2001; 14:362-367.
36. Kuijpers D, Ho KY, van Dijkman PR, Vliegenthart R, Oudkerk M. Dobutamine cardiovascular magnetic resonance for the detection of myocardial ischemia with the use of myocardial tagging. Circulation 2003; 107:1592-1597.